Evogene Newsroom

Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Cuts Target Price to $5

Futu NewsNov 22 21:33

Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Maintains Target Price $12

Futu NewsNov 21 22:32

Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Maintains Target Price $12

Futu NewsNov 20 22:32

Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Maintains Target Price $12

Futu NewsNov 19 22:31

Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Maintains Target Price $12

Futu NewsOct 31 21:31

Evogene Price Target Cut to $12.00/Share From $30.00 by Lake Street

Dow JonesAug 23 22:07

Evogene Analyst Ratings

BenzingaAug 23 21:57

Lake Street Maintains Buy on Evogene, Lowers Price Target to $12

BenzingaAug 23 21:57

Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Cuts Target Price to $12

Futu NewsAug 23 20:32

Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Maintains Target Price $30

Futu NewsAug 22 21:31

Evogene (EVGN) Gets a Buy From Lake Street

TipRanksAug 22 20:59

Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), TELA Bio (TELA) and InfuSystem Holdings, Inc. (INFU)

TipRanksMay 21 21:05

Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), Edwards Lifesciences (EW) and Nurix Therapeutics (NRIX)

TipRanksApr 11 20:01

Evogene (EVGN) Receives a Buy From Lake Street

TipRanksApr 1 21:01

Lake Street Sticks to Their Buy Rating for Evogene (EVGN)

TipRanksMar 5 22:00

Buy Rating Affirmed on Evogene's Growth Potential and Commercial Ramp-Up in 2024

TipRanksMar 1 20:46

Evogene (EVGN) Gets a Buy From Lake Street

TipRanksFeb 20 21:45

Analysts Offer Insights on Healthcare Companies: Vicarious Surgical (RBOT) and Evogene (EVGN)

TipRanksNov 14, 2023 21:50

Evogene's Resilience and Financial Stability Amid Middle East Tensions: A Buy Rating Analysis

TipRanksOct 16, 2023 20:15

Alliance Global Partners Initiates Coverage On Evogene With Buy Rating, Announces Price Target of $1.85

BenzingaOct 2, 2023 20:24